Korian - Medica: 2014 Dividend Submitted to the Annual General Meeting

Regulatory News:

Timetable - Terms

On 25 March 2015, the Board of Directors (the "Board”) of Korian - Medica (Paris:KORI) (the "Company”) decided to submit to the Annual General Meeting (the "Meeting”), to be held on 25 June 2015, the payment of a dividend, for financial year 2014, of €0.60 per share.

The Board has also decided to submit to the Meeting a resolution in order to offer to each shareholder an option for the payment of the dividend in newly issued shares of the Company; the payment in shares would apply to the whole dividend.

The new shares will be issued at a price equal to 95% of the average of the closing Korian - Medica share price for the 20 trading days preceding the date of the Meeting reduced by the net amount of the dividend, i.e. €0.60, rounded up to the nearest euro cent.

TIMETABLE AND TERMS OF THE DIVIDEND PAYMENT

• Record date: 30 June 2015
• Ex date: 1 July 2015
• Availability of the option for the payment of the dividend in newly issued shares: from 1 to 17 July 2015. Beyond that date, if the option is not exercised, the dividend will be paid in cash.
• Treatment of share fractions: if the amount of dividends, for which the option is exercised, does not correspond to a round number of shares, shareholders will receive the rounded-down whole number of shares and the balance in cash.
• Payment date: 24 July 2015 (whatever the option chosen).
• Admission and date of first entitlement of the new shares: the new shares issued as payment for the dividend, should the option be exercised, will be admitted to trading on the NYSE Euronext Paris. They will be subject to all the clauses of the Company’s Articles of Association and will carry dividend rights from 1 January 2015. Consequently, as from their issuance, they will be fully assimilated to the ordinary shares forming the Company’s share capital.

This option may be subject to legal restrictions for shareholders who are not French residents. The latter are invited to consult their legal counsel with respect to the laws and regulations applicable in their own country of residence.

Disclaimer

This press release constitutes the information document required pursuant to Articles 212-4 (§4) and 212-5 (§5) of the General Regulations of the Autorité des Marchés Financiers (the "AMF”) as well as Article 13 and Appendix III of the AMF guidelines 2005-11 dated 21 December 2005 as amended.

This press release does not constitute an offer of securities. This press release and any other document relating to the payment of the dividend in shares shall be published outside France only in accordance with local laws and regulations and shall not constitute an offer of securities in countries where such offer would violate applicable laws and regulations.

Next press release: Wednesday 6 May 2015 after close of trading

Q1 2015 revenues

ABOUT KORIAN – MEDICA

Korian - Medica, Europe’s leading Ageing Well specialist, founded in 2003, has the capacity to accommodate more than 57,500 residents and patients in Europe (France, Germany, Italy and Belgium) and employs around 40,000 staff members. The Group manages around 600 facilities in four business lines: nursing homes, post-acute and rehabilitation clinics, assisted living facilities and home-care services.

For more information, please visit the website: www.korian.com

Korian – Medica has been listed on Euronext Paris Compartment B since November 2006 and is included in the following indices: SBF 120, CAC Health Care, CAC Mid 60, CAC Mid & Small and MSCI Global Small Cap

Euronext ticker: KORI - ISIN: FR0010386334 – Reuters: KORI.PA – Bloomberg: KORI.FP